Create Free Account

By creating account you will get access to hot stocks & personalised emails

IDT Australia Ltd

Healthcare AU IDT

0.105AUD
-0.01(8.70%)

Last update at 2024-11-13T04:06:00Z

Day Range

0.100.12
LowHigh

52 Week Range

0.080.14
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap51.58M
  • Volume1145233
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.13300M
  • Revenue TTM14.02M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 1.64M
  • Diluted EPS TTM-0.02

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -9.77600M -1.87600M 0.97M -1.98100M -6.11900M
Minority interest - - - - -
Net income -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Selling general administrative 9.78M 7.08M 12.31M 11.77M 12.56M
Selling and marketing expenses - - - - -
Gross profit 4.75M 10.66M 14.15M 12.49M 9.26M
Reconciled depreciation 1.04M 1.54M 1.78M 2.03M 2.52M
Ebit -9.87300M -1.90100M 0.07M -0.57600M -5.56500M
Ebitda -8.83400M -0.36500M 1.85M 1.46M -3.04700M
Depreciation and amortization 1.04M 1.54M 1.78M 2.03M 2.52M
Non operating income net other - - - - -
Operating income -9.77600M -1.87600M 0.97M -1.24500M -5.56500M
Other operating expenses -6.02600M -4.48000M -4.82400M -12.93200M 17.70M
Interest expense - 0.03M 0.90M 1.41M 0.02M
Tax provision -1.27800M -0.71600M -1.13700M -0.06200M -0.03600M
Interest income - - 0.03M 0.07M 0.02M
Net interest income - - 0.03M 0.07M 0.22M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.27800M -0.71600M -1.13700M -0.06200M -0.03600M
Total revenue 6.93M 12.11M 16.03M 14.10M 11.88M
Total operating expenses 14.63M 12.57M 14.09M 13.80M 15.07M
Cost of revenue 2.18M 1.44M 1.87M 1.61M 2.62M
Total other income expense net 0.10M 0.03M 0.87M -0.73600M -0.55400M
Discontinued operations - - - - -
Net income from continuing ops -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Net income applicable to common shares -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 31.37M 28.29M 30.08M 34.13M 28.59M
Intangible assets - 0.00000M 0.00000M 0.12M 0.25M
Earning assets - - - - -
Other current assets 1.65M 0.19M 0.05M 1.76M 0.03M
Total liab 7.93M 4.15M 3.09M 6.51M 5.29M
Total stockholder equity 23.44M 24.14M 26.99M 27.61M 23.30M
Deferred long term liab - - - 0.12M 0.25M
Other current liab 2.30M 0.83M 0.15M 2.47M 4.51M
Common stock 57.70M 54.93M 51.19M 51.19M 51.19M
Capital stock - 54.93M 51.19M 51.19M 51.19M
Retained earnings -46.97400M -41.56100M -32.70000M -31.54000M -33.64300M
Other liab - 0.17M 0.31M 0.45M 0.34M
Good will - - - - -
Other assets - - - 0.12M 0.25M
Cash 0.50M 4.43M 9.21M 6.93M 6.86M
Cash and equivalents - - - - -
Total current liabilities 7.76M 3.98M 2.78M 6.07M 4.95M
Current deferred revenue 0.33M 2.07M 1.19M 0.25M 0.04M
Net debt 3.96M -3.69300M -8.33300M -6.16200M -6.85500M
Short term debt 4.47M 0.74M 0.88M 0.77M 0.00500M
Short long term debt - 0.74M 0.88M 0.77M -
Short long term debt total 4.47M 0.74M 0.88M 0.77M 0.00500M
Other stockholder equity - -13.36800M -18.12600M -19.64900M -17.54600M
Property plant equipment - 18.55M 16.21M 16.74M 15.53M
Total current assets 10.41M 9.74M 13.87M 17.27M 12.81M
Long term investments - - - - -
Net tangible assets - 24.14M 26.99M 27.61M 23.30M
Short term investments - - - - -
Net receivables 6.57M 2.25M 1.54M 8.12M 5.44M
Long term debt - - - - -
Inventory 1.68M 1.37M 1.10M 0.45M 0.44M
Accounts payable 0.66M 0.35M 0.55M 2.58M 0.40M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 12.71M 10.77M 8.50M 7.97M 5.75M
Additional paid in capital - - - - -
Common stock total equity - - - - 51.19M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -18.54600M -16.21500M - -
Deferred long term asset charges - - - - -
Non current assets total 20.96M 18.55M 16.21M 16.86M 15.77M
Capital lease obligations - - - - 0.00500M
Long term debt total - 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.52200M -0.91200M -0.52600M -0.76100M -0.87100M
Change to liabilities -1.18600M -1.25400M 0.64M -0.25900M 0.68M
Total cashflows from investing activities -0.52200M -0.91200M -0.52600M -0.76100M -0.87100M
Net borrowings -0.14100M 0.02M 0.02M -0.00400M -0.53300M
Total cash from financing activities 3.64M 0.34M 0.22M 0.01M -2.14300M
Change to operating activities 0.20M 0.28M -0.01000M 0.07M -0.08800M
Net income -8.49800M -1.16000M 2.10M -1.91900M -6.08300M
Change in cash -4.78100M 2.29M 0.07M -2.63700M -4.53000M
Begin period cash flow 9.21M 6.93M 6.86M 9.50M 14.03M
End period cash flow 4.43M 9.21M 6.93M 6.86M 9.50M
Total cash from operating activities -7.90200M 2.86M 0.37M -1.91000M -1.51600M
Issuance of capital stock 3.78M 0.32M 0.20M 0.02M 0.03M
Depreciation -1.03900M -1.53600M 1.78M 1.91M 2.52M
Other cashflows from investing activities - 0.00000M 0.00000M 0.00000M 0.33M
Dividends paid - - - - -
Change to inventory 0.27M -0.69800M -0.00900M 0.19M 0.07M
Change to account receivables 1.00M 7.10M -3.92000M -2.18000M 0.24M
Sale purchase of stock 3.78M 0.32M 0.20M 0.02M -1.64400M
Other cashflows from financing activities 1.23M 1.35M 1.09M -0.00400M -0.53300M
Change to netincome 0.18M 0.32M 0.28M 0.19M 0.78M
Capital expenditures 0.52M 0.91M 0.53M 0.76M 1.20M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.27M 6.40M -3.92900M -1.99000M 0.25M
Stock based compensation 0.18M 0.32M 0.31M 0.19M -
Other non cash items 1.63M 5.56M -3.51300M -1.90300M 3.56M
Free cash flow -8.42400M 1.95M -0.15600M -2.67100M -1.20100M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDT
IDT Australia Ltd		 -0.01 8.70% 0.10 - - 3.59 2.20 4.17 -1.0188
AFP
AFT Pharmaceuticals Ltd		 -0.02 0.78% 2.55 17.71 19.08 1.35 3.31 1.56 10.94
VLS
Vita Life Sciences Ltd		 - -% 2.09 12.06 - 1.46 2.42 1.15 6.64
LV1
Live Verdure Ltd		 0.03 4.29% 0.73 - - 52.75 39.01 42.66 -5.083
PER
Percheron Therapeutics Limited		 -0.003 3.53% 0.08 - - 27.59 8.75 347.00 -4.4641

Reports Covered

Stock Research & News

View All

Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

IDT Australia Ltd

45 Wadhurst Drive, Boronia, VIC, Australia, 3155

Key Executives

Name Title Year Born
Mr. Paul McDonald Interim CEO NA
Mr. Chris Kagiaros Head of People & Culture NA
Dr. David Sparling BVSc (Hons), GDipAppCGov, L.L.B., LLB (Hons) Joint company Sec. NA
Mr. Vasanthakumar Mahendran Interim Chief Financial Officer NA
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Company Sec. 1964
Mr. Paul Anthony McDonald Chief Executive Officer NA
Mr. Vasanthakumar Mahendran Chief Financial Officer NA
Mr. Jim Sosic COO & Operations Director NA
Ms. Priscilla Thiyageas Quality Director NA
Ms. Paula Coutts Head of People & Safety NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.